What is Myomo Inc. (MYO) stock price today?

Myomo Inc. (MYO) is currently trading at $1.32, down 3.31% today.

What is MYO P/E ratio?

Myomo Inc.'s P/E ratio is -5.02. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is MYO return on equity (ROE)?

Myomo Inc.'s return on equity (ROE) is -142.02%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Myomo Inc.'s market cap?

Myomo Inc. has a market capitalization of $50.81M.

AMEX · Medical - Devices

Myomo Inc. (MYO) Stock

$1.32 -3.31% AMEX: MYO Healthcare

Valuation

Metric	Value
Price	$1.32
Market Cap	$50.81M
P/E Ratio	-5.02
P/B Ratio	12.52
P/S Ratio	1.53
EPS (TTM)	$-0.26
52-Week High	$1.89
52-Week Low	$0.60
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-142.02%
ROA	-41.05%
ROCE	-47.32%
Gross Margin	65.96%
Operating Margin	-34.07%
Net Margin	-33.53%
Debt/Equity	3.44
Current Ratio	3.50

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$14.0M	$16.0M	$19.0M	$33.0M	$41.0M
Operating Profit	$-10.0M	$-11.0M	$-8.0M	$-6.0M	$-14.0M
Net Profit	$-10.0M	$-11.0M	$-8.0M	$-6.0M	$-16.0M
EPS	$-1.78	$-1.52	$-0.28	$-0.16	$-0.37
Op Margin	-74.1%	-68.6%	-42.8%	-19.1%	-35.2%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$20.0M	$10.0M	$15.0M	$42.0M	$39.0M
Total Liabilities	$5.0M	$4.0M	$6.0M	$18.0M	$27.0M
Cash	$16.0M	$5.0M	$7.0M	$24.0M	$14.0M
Borrowings	$1.0M	$1.0M	$1.0M	$8.0M	$19.0M

Latest News

iAccess Alpha Virtual Best Ideas Summer Investment Conference Begins Today ACCESS Newswire · Jun 23, 2026 iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 23–24, 2026 ACCESS Newswire · Jun 18, 2026 Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference Business Wire · Jun 16, 2026 Undervalued Penny Stocks To Consider In June 2026 Simply Wall St. · Jun 8, 2026 Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock Zacks · May 28, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-10.0M	$-10.0M	$-6.0M	$-3.0M	$-15.0M
Investing Cash Flow	$-1.0M	$0	$-2.0M	$-1.0M	$-9.0M
Financing Cash Flow	$0	$0	$0	$1.0M	$0
Net Cash Flow	$3.0M	$-10.0M	$2.0M	$18.0M	$-10.0M
Free Cash Flow	$-10.0M	$-10.0M	$-6.0M	$-5.0M	$-16.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.12
EV / EBITDA	-6.58
FCF Yield	-13.37%
Quick Ratio	2.01
Interest Coverage	-6.54
Return 1Y	-44.00%
Return 3Y	40.00%
Return 5Y	-86.93%

Ownership

Insiders Held9.10%

Institutions Held40.62%

Institutions Float Held44.69%

Institutional Holder	Shares	Report Date
Rosalind Advisors, Inc.	3,847,272	2026-03-31
Blackrock Inc.	1,688,390	2026-03-31
Vanguard Capital Management LLC	1,144,324	2026-03-31
Geode Capital Management, LLC	858,799	2026-03-31
Jefferies Financial Group Inc.	704,275	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ECORelectroCore, Inc.	$8.57	-7.65%	-5.72	$77.27M	0.00%
HYPDHyperion DeFi, Inc.	$3.38	-2.59%	-1.19	$51.23M	0.00%
IGCIGC Pharma, Inc.	$0.26	-4.17%	-3.34	$26.47M	0.00%
MIRAMIRA Pharmaceuticals, Inc.	$0.67	-5.40%	-0.53	$28.04M	0.00%
MLSSMilestone Scientific, Inc.	$0.33	-5.99%	-7.97	$28.94M	0.00%

About Myomo Inc.

Myomo Inc. is led by CEO Paul R. Gudonis, employs 184 people, headquartered in US, publicly traded since 2017.

Myomo Inc. (MYO) stock trades at $1.32 with a market capitalization of $50.81M. The stock is valued at a negative price-to-earnings (P/E) ratio of -5.02, reflecting a net loss over the last twelve months, price-to-book of 12.52, price-to-sales of 1.53. Over the past 52 weeks the stock has ranged between $0.60 and $1.89, and currently trades 30.2% below its 52-week high.

On profitability, Myomo Inc. generates a return on equity (ROE) of -142.02% (negative, reflecting a net loss), return on capital employed of -47.32%, an operating margin of -34.07%, a net profit margin of -33.53%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1167.67 -1.26% JNJ Johnson & Johnson $249.17 -5.52% ABBV AbbVie Inc. $274.64 -2.31% MRK Merck & Company, Inc. Common Stock (new) $141.85 -2.48% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.41 -0.29% NVS Novartis AG $142.75 -0.76% TMO Thermo Fisher Scientific Inc $665.23 +0.45% AZN AstraZeneca PLC $156.33 -1.26% AMGN Amgen Inc. $413.15 -1.06% GILD Gilead Sciences, Inc. $147.99 -1.62% ABT Abbott Laboratories $103.01 +1.17% NVO Novo Nordisk A/S $38.03 -1.43%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.